These authors share equal first authorship.A n acute inflammatory response to an insult is largely a protective cellular response. An unopposed acute inflammatory process persists, leading to the characteristic chronic inflammation. Commonly, the sequel would be a deterioration of physiological function. An early intervention is therefore important to reduce or eliminate this undesirable consequence. To this end, several biomarkers of inflammation have been measured and tested; these biomarkers are mainly the products of enzymatic reactions. Caspase-1 is one of the most prominent of the enzymes involved in inflammation. 1 Inflammation can be induced by numerous exogenous agents, including airborne particles, biological aggregates, nanocrystals (quantum dots (QDs)) and lipopolysaccharides (LPS). 2 These inflammagens are recognized by macrophages and microglia and some of them bind to cell surface receptors such as Toll-like receptors (TLR). In particular, endotoxins, including LPS, bind TLR-4 and trigger receptor dimerization at the plasma membrane, which, in turn, activate signal transduction cascades to induce inflammation. 1 TLR-4 activation initiates both genomic and nongenomic inflammatory responses (i) by activating the transcription factor NF-κB, which translocates to the nucleus and induces the expression of pro-inflammatory cytokines (e.g., pro-interleukins), and (ii) by internalizing the bound endotoxin stimuli, fusing with lysosomes and triggering the formation of inflammasomes ( Figure 1A). Nod-like receptor protein-3 (NLRP-3) inflammasome 3À6 is one of the most wellstudied inflammasomes and contains the precursor pro-caspase-1, which is cleaved following inflammatory stimuli and releases its active form, caspase-1. 7 Caspase-1 is a cysteine protease which converts * Address correspondence to dusica.maysinger@mcgill.ca.Received for review January 14, 2013 and accepted October 9, 2013.
Published online 10.1021/nn404473gABSTRACT Although caspase-1 is a key participant in inflammation, there is no sensitive assay to measure its enzymatic activity in real time in cells or animals. Here we describe a nanosensor for caspase-1 ratiometric measurements, consisting of a rhodamine-labeled, caspase-1 cleavable peptide linked to quantum dots (QDs). Microglia cells were stimulated by lipopolysaccharide (LPS) and by hybrid nanoparticles LPSÀQDs. These stimuli activated caspase-1 in microglia monolayers and in the mouse brain, while a selected caspase inhibitor markedly reduced it. LPSÀQDs entered into the lysosomal compartment and led to an enlargement of these cellular organelles in the exposed microglia. Both lysosomal swelling and mitochondrial impairment contributed to caspase-1 activation and to the consequent interleukin-1β release. The results from these studies highlight how the unique properties of QDs can be used to create versatile biotools in the study of inflammation in real time in vivo.